康抗生物

Biotech/Healthcare

KangKang Biotech is a biotechnology company focused on developing innovative medicines to address unmet clinical needs. The company develops innovative prodrug molecules based on immune agonists and multispecific antibodies to reduce drug toxicity and improve therapeutic efficacy.

Latest round: Pre Series A (2023)